
Metolod 47.5mg Tablet ER
Marketer
Meddox Formulations
Salt Composition
Metoprolol Succinate (47.5mg)
Overview Metolod 47.5mg Tablet ER
Belonging to the beta-blocker class, Cardiogard 47.5mg Extended-Release tablets manage hypertension, angina pectoris, and cardiac arrhythmias. This medication also contributes to migraine prevention and reduces the risk of future myocardial infarction and cerebrovascular accident. Cardiogard 47.5mg ER may be administered independently or in conjunction with other therapies; dosage and frequency are individualized based on the treated condition and its severity. Administer consistently at the same time daily, with or without food, for optimal efficacy. Complete therapeutic benefit may take weeks to manifest, and continuous use might be necessary. Discontinuation may exacerbate underlying conditions, even in the absence of noticeable symptoms. Common, usually transient, side effects include fatigue, cephalgia, depressive symptoms, diarrhea, dermatological reactions, bradycardia, dizziness, and nausea. Hypotension and dyspnea are less frequent possibilities. Gradual dose escalation minimizes adverse effects. Report persistent or bothersome side effects to your physician. Pre-existing hepatic impairment, bradycardia, significant circulatory compromise, severe congestive heart failure, or hypotension should be disclosed prior to initiating therapy. Consult your physician before use during pregnancy or lactation. Individual suitability must be determined by your doctor, who should also monitor blood pressure regularly to assess treatment effectiveness. Alcohol consumption should be limited due to the potential for increased side effects.
Primary Ingredients of Metolod 47.5mg Tablet ER
No text provided. Please provide the text you would like me to rephrase.
Uses of Metolod 47.5mg Tablet ER
Managing angina pectoris (chest pain from heart issues)|Correcting cardiac arrhythmias|Cardiovascular event prevention|Hypertension (high blood pressure) management|Migraine prophylaxis
Major Benefits of Metolod 47.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 47.5mg Metolod Extended-Release tablet whole; do not chew, crush, or break it. While it can be taken with or without food, consistent timing is recommended. Limit consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and meat while using Metolod 47.5mg Tablet ER.
Common Side effects of Metolod 47.5mg Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metolod 47.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Metolod 47.5mg Extended-Release tablet whole; do not chew, crush, or break it. This medication can be taken with or without food, but consistency in timing is recommended. Limit consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and meat while taking Metolod 47.5mg Tablet ER.
How Metolod 47.5mg Tablet ER works:
Extended-release Metolod 47.5mg tablets are a cardioselective beta-adrenergic blocker. This medication reduces heart rate and improves the heart's pumping efficiency, promoting better circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metolod 47.5mg Extended-Release tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metolod 47.5mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metolod 47.5mg tablets are likely safe for breastfeeding mothers. Available evidence from humans indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Metolod 47.5mg tablets can reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Metolod 47.5mg tablets are considered safe for use in individuals with kidney impairment. No modification of the Metolod 47.5mg extended-release tablet dosage is necessary.
LiverCAUTION
Extended-release Metolod 47.5mg tablets require careful administration for individuals with hepatic impairment. Dosage modification of Metolod 47.5mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Metolod 47.5mg Tablet ER :
Should you forget a Metolod 47.5mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metolod 47.5mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | HEART |
